Cytochrome P450 19A1 (Aromatase) transcriptional machinery (CYP19A1 transcriptional machinery)

The Aromatase transcriptional machinery refers to the complex network of tissue-specific promoters and transcription factors that regulate the expression of the CYP19A1 gene, which encodes the aromatase enzyme responsible for converting androgens to estrogens (Bulun et al., 2005, PMID: 15591012). In humans, aromatase expression is controlled by at least ten distinct promoters (e.g., I.1, I.3, I.4, and II) that are utilized in a tissue-specific manner, such as in the ovary, placenta, bone, and adipose tissue (Chen et al., 2009, PMID: 19150454). In diseases like breast cancer and endometriosis, a characteristic "promoter switch" occurs where the gene expression shifts from the distal, cytokine-regulated promoter I.4 to the proximal, cAMP-regulated promoters II and I.3, leading to pathologically high local estrogen levels (Ghosh et al., 2021, PMID: 33466444). Therapeutic strategies targeting this machinery aim to selectively inhibit aromatase expression in specific tissues by modulating transcription factors like Steroidogenic Factor 1 (SF-1) or Liver Receptor Homolog 1 (LRH-1), or by inhibiting upstream signaling pathways like the COX-2/PGE2 axis (Simpson et al., 2002, PMID: 11834451). This approach offers a potential advantage over traditional aromatase inhibitors by reducing systemic side effects while maintaining local control of estrogen production.

Other names

Aromatase regulatory complexCYP19A1 promoter complexAromatase expression machineryAromatase transcriptional regulation

Inhibition of tissue-specific promoter activation and transcription factor recruitment to the CYP19A1 gene